Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
usx:edit usx:crsp usx:ntla usx:beam Blog PostHere’s what Cathie Wood has been buying for her flagship Ark fund!
usx:twlo usx:crsp usx:exas Blog PostHere’s what star stock picker Cathie Wood bought after the market correction!
usx:arkk usx:crsp usx:pacb usx:nvta Blog PostWhy Vertex Is Striking Another Gene-Editing Deal With a Company Not Named CRISPR Therapeutics
usx:vrtx usx:crsp Blog PostWhy Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics
usx:vrtx usx:crsp Blog PostWhy CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics Stocks Are Sinking Today
usx:edit usx:crsp usx:ntla Blog PostCathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought
usx:crsp usx:nvta usx:psnl Blog PostWhy Shares of Bluebird Bio, CRISPR Therapeutics, and Editas Medicine Soared This Week
usx:edit usx:crsp usx:blue Blog PostThe Best 3 Stocks in Cathie Wood's Ark ETF Have 1 Thing in Common
usx:arkk usx:crsp usx:cers usx:sgfy Blog Post